Rovalpituzumab tesirine for treating small-cell lung cancer after 2 therapies [ID1288]

  • Discontinued
  • GID-TA10212

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators